BOOK COLD WARS: The ZICAM Story “USC was wild—sex, drugs, rock and roll”

  • Home
  • CELEBRITY ENDORSEMENT
  • COLD WARS:THE ZICAM STORY
  • COLD WARS MOVIE
  • COLD WARS TV SERIES
  • **MADE IN JAPAN**
  • GALLERY
  • BIO
  • LOUIS GOSSETT JR.
  • SHANNON BRIGGS
  • HENSLEY CORPORATE GROUP
    • ZICAM
    • VIRA 38
    • Theramax
    • Migranade
  • DISMISSAL OF CASES
  • Contact Us
  • More
    • Home
    • CELEBRITY ENDORSEMENT
    • COLD WARS:THE ZICAM STORY
    • COLD WARS MOVIE
    • COLD WARS TV SERIES
    • **MADE IN JAPAN**
    • GALLERY
    • BIO
    • LOUIS GOSSETT JR.
    • SHANNON BRIGGS
    • HENSLEY CORPORATE GROUP
      • ZICAM
      • VIRA 38
      • Theramax
      • Migranade
    • DISMISSAL OF CASES
    • Contact Us
  • Home
  • CELEBRITY ENDORSEMENT
  • COLD WARS:THE ZICAM STORY
  • COLD WARS MOVIE
  • COLD WARS TV SERIES
  • **MADE IN JAPAN**
  • GALLERY
  • BIO
  • LOUIS GOSSETT JR.
  • SHANNON BRIGGS
  • HENSLEY CORPORATE GROUP
    • ZICAM
    • VIRA 38
    • Theramax
    • Migranade
  • DISMISSAL OF CASES
  • Contact Us

Dismissal of cases against Dr. Charles B. Hensley


The Securities and Exchange Commission (SEC) civil case against Desilu Studios Inc. and Charles B. Hensley, along with a related criminal case against Hensley, were indeed terminated in late 2023.



Specifically, the criminal case, United States v. Hensley, 2:22-cr-00361, (C.D. Cal.) was terminated on November 2, 2023. The SEC's civil case, Securities and Exchange Commission v. Desilu Studios, Inc., 2:22-cv-05652, (C.D. Cal.), was terminated on October 24, 2023.


 This suggests that the legal disputes regarding Desilu Studios, which involved allegations of fraud and the misuse of the Desilu name to lure investors, have concluded with the termination of both the criminal and civil proceedings against Charles B. Hensley and Desilu Studios Inc

Copyright © 2025 Charles Benjamin Hensley  - All Rights Reserved.

  • Terms and Conditions
  • Privacy Policy

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept